BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28664531)

  • 1. The role of RhoC in malignant tumor invasion, metastasis and targeted therapy.
    Guan X; Chen S; Zhao Y
    Histol Histopathol; 2018 Mar; 33(3):255-260. PubMed ID: 28664531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formin-like 3 regulates RhoC/FAK pathway and actin assembly to promote cell invasion in colorectal carcinoma.
    Zeng YF; Xiao YS; Liu Y; Luo XJ; Wen LD; Liu Q; Chen M
    World J Gastroenterol; 2018 Sep; 24(34):3884-3897. PubMed ID: 30228782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target.
    Thomas P; Pranatharthi A; Ross C; Srivastava S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):328. PubMed ID: 31340863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.
    Lin M; DiVito MM; Merajver SD; Boyanapalli M; van Golen KL
    Mol Cancer; 2005 Jun; 4(1):21. PubMed ID: 15969750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma.
    Chang RM; Pei L; Fang F; Xu JF; Yang H; Zuo CH; Zhou JH; Luo GQ; Yang LY
    Oncotarget; 2016 Aug; 7(34):55585-55600. PubMed ID: 27487132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA and RhoC are involved in stromal cell-derived factor-1-induced cell migration by regulating F-actin redistribution and assembly.
    Luo J; Li D; Wei D; Wang X; Wang L; Zeng X
    Mol Cell Biochem; 2017 Dec; 436(1-2):13-21. PubMed ID: 28536953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
    Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
    Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
    Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
    Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9.
    Wang Q; Tang H; Yin S; Dong C
    Oncol Rep; 2013 May; 29(5):2046-52. PubMed ID: 23446431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of RHOC is associated with metastasis of gastric carcinomas.
    Kondo T; Sentani K; Oue N; Yoshida K; Nakayama H; Yasui W
    Pathobiology; 2004; 71(1):19-25. PubMed ID: 14555841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
    Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
    Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arg188 drives RhoC membrane binding.
    Patel A; Williams-Perez S; Peyton N; Reicks A; Buzick J; Farley J; Shirar S; Ellerbroek SM
    Small GTPases; 2017 Apr; 8(2):114-121. PubMed ID: 27355867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
    Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish.
    Stoletov K; Montel V; Lester RD; Gonias SL; Klemke R
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17406-11. PubMed ID: 17954920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoC is essential for the metastasis of gastric cancer.
    Liu N; Zhang G; Bi F; Pan Y; Xue Y; Shi Y; Yao L; Zhao L; Zheng Y; Fan D
    J Mol Med (Berl); 2007 Oct; 85(10):1149-56. PubMed ID: 17549441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
    Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E
    Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma.
    Jiang L; Liu X; Kolokythas A; Yu J; Wang A; Heidbreder CE; Shi F; Zhou X
    Int J Cancer; 2010 Aug; 127(3):505-12. PubMed ID: 20232393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
    Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
    Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.